Loading chat...
HI HB2225
Bill
Status
Introduced
1/28/2026
Primary Sponsor
Tina Grandinetti
Click for details
AI Summary
- Prohibits pharmacy benefit managers (PBMs) and prescription drug benefit plans from discriminating against pharmacies or pharmacists regarding participation, referral, reimbursement, or indemnification
- Requires beneficiary cost sharing to be calculated at point of sale based on prices reduced by 100% of all rebates received by PBMs or plan providers, with excess rebates applied to reduce premiums
- Establishes minimum pharmacy reimbursement rates at the national average drug acquisition cost (or wholesale acquisition cost if unavailable) plus a professional dispensing fee matching Hawaii Medicaid rates
- Prohibits PBMs from reimbursing independent pharmacies at rates lower than they reimburse their own affiliated pharmacies for the same prescription drug
- Requires prescription drug benefit plans executed, amended, or renewed after July 1, 2027 to use pass-through pricing or pass any spread pricing savings on to beneficiaries, with violations subject to fines up to $10,000 per occurrence
Legislative Description
Relating To Health.
Reimbursement
Last Action
Referred to HLT, CPC, referral sheet 5
1/30/2026
Committee Referrals
Health1/30/2026
Full Bill Text
No bill text available